Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Tetrabutylammonium Fluoride | HCID 2724141 | — |
| Reactant | HCID 58374105 | HCID 58374105 | — |
| Reactant | HCID 87214058 | HCID 87214058 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 66955235 | HCID 66955235 | — |
Reaction Steps
5-Phenyl-4-(trifluoromethyl)isoxazole-3-carbonyl fluoride, Int-II-D (150 mg, 0.58 mmol) was dissolved in acetonitrile (10 mL) and DIEA (0.185 mL, 1.061 mmol) and ethyl 2-((3R)-1-(2-hydroxy-2-(4-((Z)—N′-hydroxycarbamimidoyl)phenyl)ethyl)piperidin-3-yl)acetate (185 mg, 0.530 mmol) were added. After one hr, TBAF in THF (0.530 mL, 0.530 mmol) was added and the reaction mixture was stirred overnight at room temperature. LCMS shows two new peaks. One is the desired mass and the other has a much higher mass which corresponds to double addition of acid fluoride. The reaction mixture was diluted with ethyl acetate and washed with saturated NaCl. The organic layer was dried with MgSO4, filtered, and concentrated. Solids were purified by a silica gel cartridge using an EtOAc/hexanes gradient to yield 72 mgs of ethyl 2-((3R)-1-(2-hydroxy-2-(4-(5-(5-phenyl-4-(trifluoromethyl)isoxazol-3-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperidin-3-yl)acetate. MS (m+1)=571. HPLC Peak RT=3.39 minutes.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08399451B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-fc763b1c63464962a4339133fbb7db1f |
|---|
| Source note | uspto-grants-2013_03 |
|---|